BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 2578396)

  • 1. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
    Pawelec G; Schneider EM; Müller C; Wernet P
    Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex restriction of tetanus toxoid-specific human T lymphocyte clones.
    Schmitt C; Cogné M; Agrapart M; Ballet JJ
    Eur J Immunol; 1984 Dec; 14(12):1131-6. PubMed ID: 6083872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
    J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of in vitro immune responses in humans using T cell clones and monoclonal antibodies].
    Ogasawara K
    Hokkaido Igaku Zasshi; 1984 May; 59(3):346-55. PubMed ID: 6207087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibition of human antigen-specific T cell clone proliferative responses by distinct monoclonal anti-HLA-DR antibodies.
    Triebel F; Missenard-Leblond V; Couty MC; Charron DJ; Debre P
    J Immunol; 1984 Apr; 132(4):1773-8. PubMed ID: 6199412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus-transformed B-cell lines as requirement for antigen-presenting cells.
    Vyakarnam A; Lachmann PJ
    Immunology; 1984 Dec; 53(4):601-10. PubMed ID: 6209204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: evidence from studies of proliferative responses to SB antigens.
    Biddison WE; Rao PE; Talle MA; Goldstein G; Shaw S
    J Immunol; 1983 Jul; 131(1):152-7. PubMed ID: 6190904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
    Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
    J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of the OKT4 molecule in T-cell recognition of class II HLA antigens.
    Biddison WE; Shaw S
    Diagn Immunol; 1983; 1(3):112-5. PubMed ID: 6209053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity.
    Bontrop R; Ottenhoff T; Van Miltenburg R; Elferink D; De Vries R; Giphart M
    Eur J Immunol; 1986 Feb; 16(2):133-8. PubMed ID: 3485528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V.
    Huang SK; Zwollo P; Marsh DG
    Eur J Immunol; 1991 Jun; 21(6):1469-73. PubMed ID: 2044656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of alloproliferative T lymphocyte clones correlates better with their class II recognitive specificity than with their cell surface phenotype.
    Pawelec G; Schneider EM; Wernet P
    Eur J Immunol; 1985 Feb; 15(2):163-7. PubMed ID: 3871698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.
    Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C
    Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.